R

Revolution Medicines

Clinical-stage oncology company developing RAS inhibitors

Senior Oncology Account Manager

Field SalesConfirmed live in the last 24 hours
Full-timeRemote in USA

About the Job

Requirements

  • A MA, MS, BA, or BS degree and 12–15+ years of biopharma industry experience.
  • 8–12+ years of prior experience in oncology product sales.
  • A proven track record of product launch success in the oncology therapeutic space.
  • Oral oncolytic product launch experience.
  • Experience launching oncology products with companion diagnostics.
  • A record of performance in highly competitive marketplaces and solo-representative selling environments.
  • Demonstrated success operating in small- or midsize biotechnology environments.
  • Ability to meet territorial travel requirements and travel to meetings, training, and programs as necessary.
  • Effectiveness in highly collaborative and cross-functional working environments.
  • A valid driver's license.
  • Must permanently reside in the territory for which they are accountable.
  • Approximately 50% travel is required.
  • Experience in the NSCLC oncology space is preferred.
  • An advanced degree (MBA, PharmD, or PhD) is preferred.
  • Strong organization, planning, project management, technical, and analytical skills are preferred.
  • Other relevant experience, such as sales operations, market research, or market access, is preferred.
  • Ability to work independently to execute strategic and tactical plans under tight timelines is preferred.
  • Ability to deliver compelling presentations to individuals and groups, adapting messaging to maximize audience engagement, is preferred.
  • High proficiency in Microsoft PowerPoint, Excel, and Word is preferred.

Responsibilities

  • Effectively market Revolution Medicines’ product portfolio in the designated territory.
  • Exceed assigned territory performance goals by positioning the benefits and use of the company’s products for appropriate patients.
  • Direct engagement efforts toward activities that drive brand value and positively impact patients.
  • Partner with key internal stakeholders to remove barriers to care and ensure eligible patients receive timely access to company products.
  • Flex between virtual and in-person engagements and develop business plans that account for customer communication preferences.
  • Analyze market data and turn insights into effective business plans, implementing them by engaging key targets through call optimization and resource utilization.
  • Develop sustained customer relationships across assigned accounts and challenge customers through innovative, value-driven solutions.
  • Represent company brands professionally, compliantly, ethically, and effectively.
  • Maintain a thorough understanding of disease states, company products, and competitor offerings, and articulate value across digital and live communication channels.
  • Understand the reimbursement process and fulfillment pathways for oral oncolytics.
  • Manage the territory effectively and apply strong selling competencies.
  • Creatively gain access to customers in the modern landscape.
  • Drive team effectiveness and shared goals by leveraging and sharing expertise and information.
  • Manage territory resources and budget effectively.
  • Comply with laws, regulations, and policies governing staff conduct.
  • Model corporate core values while cultivating an energized team culture focused on patient impact.

Desired Qualifications

  • Experience in the NSCLC oncology space.
  • An advanced degree (MBA, PharmD, or PhD).
  • Strong organization, planning, project management, technical, and analytical skills.
  • Other relevant experience, such as sales operations, market research, or market access.
  • Ability to work independently to execute strategic and tactical plans under tight timelines.
  • Ability to deliver compelling presentations to individuals and groups, adapting messaging to maximize audience engagement.
  • High proficiency in Microsoft PowerPoint, Excel, and Word.

About the Company

Revolution Medicines

Clinical-stage oncology company developing RAS inhibitors

Revolution Medicines develops precision oncology drugs focused on cancers driven by RAS mutations. Its RAS(ON) inhibitors are small molecules that bind the active form of RAS to block cancer signaling, with candidates like Daraxonrasib (RMC-6236), Elironrasib (RMC-6291), and Zoldonrasib (RMC-9805) advancing in global Phase 3 trials. The company funds its research through collaborations, royalties, and upfront funding, and has not yet marketed a product. Its goal is to bring effective RAS-targeted therapies to patients and advance multiple candidates through late-stage trials toward approval, supported by strong cash reserves.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Redwood City, CA
Founded
2014

Recently Posted Jobs

Explore more opportunities at Revolution Medicines

See more jobs